Functional Assessment of Cancer Therapy - Bone Marrow Transplant (FACT-BMT)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2011 by King Faisal Specialist Hospital & Research Center.
Recruitment status was  Recruiting
Sponsor:
Information provided by (Responsible Party):
King Faisal Specialist Hospital & Research Center
ClinicalTrials.gov Identifier:
NCT01490957
First received: December 11, 2011
Last updated: NA
Last verified: December 2011
History: No changes posted
  Purpose

Functional Assessment of Cancer Therapy - Bone Marrow Transplant


Condition Intervention
Hodgkin Disease
Lymphoma, Non-Hodgkin
Other: Database

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Functional Assessment of Cancer Therapy - Bone Marrow Transplant (FACT-BMT)

Resource links provided by NLM:


Further study details as provided by King Faisal Specialist Hospital & Research Center:

Estimated Enrollment: 113
Study Start Date: March 2008
Intervention Details:
    Other: Database
    Database
    Other Name: Database of Newly Diagnosed HD and NHL
Detailed Description:

Functional Assessment of Cancer Therapy - Bone Marrow Transplant (FACT-BMT)

  Eligibility

Ages Eligible for Study:   14 Years to 85 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Lymphoma database

Criteria

Inclusion Criteria:

  • Patients with newly diagnosed Hodgkin's Disease and Non-Hodgkin's Lymphoma

Exclusion Criteria:

  • Patients with diagnosis other than HD and NHL.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01490957

Contacts
Contact: A Al-Zahrani, M.D. +966-1-4423949

Locations
Saudi Arabia
Kfsh & Rc Recruiting
Riyadh, Saudi Arabia
Sponsors and Collaborators
King Faisal Specialist Hospital & Research Center
Investigators
Principal Investigator: A Al-Zahrani, M.D. KFSH & RC
  More Information

No publications provided

Responsible Party: King Faisal Specialist Hospital & Research Center
ClinicalTrials.gov Identifier: NCT01490957     History of Changes
Other Study ID Numbers: RAC# 2071-079, RAC# 2071-079
Study First Received: December 11, 2011
Last Updated: December 11, 2011
Health Authority: United States: Institutional Review Board

Keywords provided by King Faisal Specialist Hospital & Research Center:
HD
NHL

Additional relevant MeSH terms:
Hodgkin Disease
Lymphoma
Lymphoma, Non-Hodgkin
Neoplasms by Histologic Type
Neoplasms
Lymphoproliferative Disorders
Lymphatic Diseases
Immunoproliferative Disorders
Immune System Diseases

ClinicalTrials.gov processed this record on April 15, 2014